Patients’ perspectives on palliative chemotherapy of colorectal and non - colorectal cancer: a prospective study in a chemotherapy- experienced population

Table 3 Multi-factorial ANOVA

Independent factors	Survival threshold
	Regression coefficient	Significance
*Disease group*
CRC vs. Non-CRC	- 0.289	0.032
*Sex*
Male vs. Female	- 0.013	0.921
*Age*
< 60 vs. 60-69 vs. ≥ 70	- 0.054	0.638
*Anxiety*
None vs. Possible vs. Likely	0.195	0.168
*Depression*
None vs. Possible vs. Likely	- 0.439	0.020
*Stomatitis*
None vs. Grade 1/2 vs. Grade 3/4	0.209	0.117
*Nausea*
None vs. Grade 1/2 vs. Grade 3/4	0.110	0.424
*Vomiting*
None vs. Grade 1/2 vs. Grade 3/4	−0.078	0.564
*Diarrhea*
None vs. Grade 1/2 vs. Grade 3/4	- 0.267	0.032
*Fatigue*
None vs. Grade 1/2 vs. Grade 3/4	0.179	0.177
*Sensory Neuropathy*
None vs. Grade 1/2 vs. Grade 3/4	0.218	0.115
*Skin Toxicity*
None vs. Grade 1/2 vs. Grade 3/4	0.109	0.396
*Alopecia*
None vs. Grade 1 vs. Grade 2	0.107	0.404
*Pain*
None vs. Mild vs. Moderate vs. Severe	0.176	0.176

Dependent factor: survival threshold; independent factors: disease group, age, sex, psychological morbidity, toxicity, and pain.

ISSN: 1471-2407